- Home
- SINT vs DLXY Comparison
SINT vs DLXY Comparison
Compare SINT & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SINT | DLXY |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 13.9M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SINT | DLXY |
|---|---|---|
| Price | $4.14 | $0.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 65.5K | 52.1K |
| Earning Date | 11-13-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $1,270,000.00 | ★ $314,916,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $80.00 | N/A |
| P/E Ratio | ★ N/A | $14.21 |
| Revenue Growth | N/A | ★ 8.90 |
| 52 Week Low | $1.71 | $0.64 |
| 52 Week High | $7.36 | $7.16 |
Technical Indicators
Market Signals| Indicator | SINT | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 61.64 | N/A |
| Support Level | $3.15 | N/A |
| Resistance Level | $3.50 | N/A |
| Average True Range (ATR) | 0.31 | 0.00 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 91.18 | 0.00 |
Price Performance
Historical ComparisonAbout SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About DLXY Delixy Holdings Limited Ordinary Shares
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.